Celestica (NYSE: CLS ) (TSX: CLS:CA ) has played out as per my expectations with a solid outperformance vs the S&P 500 ( SPY ) ( SPX ) ( IVV ) ( VOO ) since my last update on the stock:Providing alpha-generating investment ideas. I am an independent investor managing my family's portfolio, primarily via a Self Managed Super Fund. You can expect my articles to deliver a clearly structured, evidence-based thesis. But first and foremost, I encourage readers to judge me on my performance.I have a generalist app ...

Emerging juggernaut While Nvidia (NVDA) and other Magnificent 7 members have grabbed headlines over the past year, one AI player has stood ahead of the pack in terms of sheer returns. Palantir (PLTR) is up a whopping 514% in the last 12 months, and just took its next leg up in AH trading on Monday to top the $100 level for the first time. Stellar earnings from the AI software analytics company were responsible for the nearly 23% pop, while it projected bumper numbers for 2025 amid accelerating AI adop ...

SANTA CLARA, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced the recipients of Supplier Excellence Awards for contributions made to Applied's business over the past year. The awards reflect outstanding technical and operational performance in areas including quality, service, sustainability, lead time, delivery, cost and responsiveness. "Congratulations to our Supplier Excellence Award recipients for providing extraordinary levels of performance, agility and quality in supp ...

Multi-pronged media campaign to raise awareness about the disease and its impact on patients, family members and caregivers.Interactive, stand-alone NETHERTON NOW website launched.Quoin’s QRX003 product is on track to obtain the first regulatory approval for Netherton Syndrome. ASHBURN, Va., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, has launched the “NETHERTON ...

South Pacific Metals Announces Closing of Upsized C$6.3 Million Financing and Welcomes Jonathan Rubenstein to Its Board of DirectorsCompany Retains Agentis Capital Mining Partners for Advisory ServicesFebruary 04, 2025 7:30 AM EST | Source: South Pacific Metals Corp.Vancouver, British Columbia--(Newsfile Corp. - February 4, 2025) - South Pacific Metals Corp. (TSXV: SPMC) (FSE: 6J00) ("SPMC" or the "Company") is pleased to announce that is has closed its previously announced non-brokered privat ...

Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives. 438 testimonials and most are 5 stars. Nothing to lose with our FREE 2-week trial .On October 10, I wrote an article titled “The One Chart That Keeps Me Up At Night.” That chart is the one below, which shows the purchasing power of the U.S. dollar. Since 1933, it has been in steady decline, causingAnalyst’s Disclosure: I/we have a beneficial long position in t ...

Full year 2024 sales of $4.4 billion represents ATI's highest total since 2012 Q4 2024 sales of $1.2 billion, up 10% over Q4 2023; full year 2024 sales of $4.4 billion, up 5% over full year 2023 Q4 2024 net income attributable to ATI of $137 million, or $0.94 per share; full year 2024 net income attributable to ATI of $368 million, or $2.55 per share Aerospace and defense represent 65% of Q4 2024 sales, up from 62% of Q3 2024 sales and 63% of Q4 2023 sales Full year 2024 operating cash flow of $407 million, ...

Tesla (TSLA -5.17%) Chief Executive Officer Elon Musk is no stranger to hyperbole.Musk, who also runs SpaceX and a number of other companies, has been known to make big often exaggerated promises. For example, he once called the Hyperloop, which was never built, the "fifth mode of transport" and famously promised to take Tesla private in a Twitter post, saying he had secured financing that he didn't have. However, Musk also has a track record of eventually fulfilling some of his big promises. For example, t ...

ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s management team will participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference, being held virtually, on February 11-12, 2025. Details are as follows: Oppenheimer’s 35th Annual Healthcare Life Sciences ConferenceConference Date: February 11-12, 202 ...

Myriad Uranium Enters into Option to Acquire 100% of the Red Basin Uranium Project in New Mexico, USAFebruary 04, 2025 7:30 AM EST | Source: Myriad Uranium Corp.Vancouver, British Columbia--(Newsfile Corp. - February 4, 2025) - Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce that it has entered into a property option agreement dated as of January 30, 2025 (the "Option Agreement") with First American Uranium Inc. ("First American"; CSE: ...